Description:

Study ID: 111569 Clinical Study ID: 111569 Study Title: A fixed dose, dose-response study for ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01494532 Sponsor: GlaxoSmithKline Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Ropinirole, placebo Study Indication: Parkinson's Disease

Keywords:
Versions (1) ▾
  1. 11/20/19
Copyright Holder:
GlaxoSmithKline
Uploaded on:

November 20, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease

Screening - Consent Demographics; Central Laboratory; Dermatological Neurological Exam; ECG

Administrative
Informed Consent
Demography
Central Laboratory
Central Laboratory - Possible Liver Events
Dermatological Exam
Neurological Exam
Neurological Exam
12 Lead Electrocardiogram
beats/min
ms
ms
ms
ms
ms
ms